Astex Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial

News   Jun 25, 2012

 
Astex Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial
 
 
 

RELATED ARTICLES

Scientists Report The Development of a Potent New Medicine to Fight Addiction

News

Scientists report the development of a potent new medicine to fight addiction.

READ MORE

Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain Therapeutics

News

The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.

READ MORE

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE